Xeris Pharmaceuticals | XERS - Ebit

Stock Price
6.68
Daily Change
0.10 1.52%
Monthly
-10.70%
Yearly
82.51%
Q1 Forecast
6.41

Xeris Pharmaceuticals reported $7.89M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Celltrion KRW 301.04B 58.57B Sep/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Deva Holding AS TRY 820.88M 192.13M Sep/2023
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 300K Dec/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Ovoca Bio EUR -5.65M 3.45M Jun/2022
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pharma Mar EUR -3.96M 28.11M Sep/2025
Qiagen NV USD 121.88M 19.18M Dec/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Tilray USD -20.01M 9.34M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025